SIEGE

• Research type

  Research Study

• Full title

  Scheduling nab-paclItaxEl with GEmcitabine (SIEGE): Randomised phase II trial to investigate two different schedules of nab-paclitaxel (Abraxane) combined with gemcitabine as first line treatment for metastatic pancreatic ductal adenocarcinoma

• IRAS ID

  130640

• Contact name

  Pippa Corrie

• Contact email

  pippa.corrie@addenbrookes.nhs.uk

• Sponsor organisation

  Cambridge University Hospitals NHS Foundation Trust

• Eudract number

  2013-001868-40

• REC name

  HSC REC B

• REC reference

  13/NI/0143

• Date of REC Opinion

  1 Nov 2013

• REC opinion

  Further Information Favourable Opinion